Uridine

규격

58-96-8CAS 번호

200-407-5EC 번호

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dioneIUPAC 명칭

C9H12N2O6화학식

244.2 g/mol분자량

uridine; 58-96-8; Uridin; Uracil riboside; 1-beta-D-Ribofuranosyluracil; CHEBI:16704; WHI7HQ7H85; DTXSID40891555; NSC-20256; NSC20256; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; Allo Uridine; Allo-Uridine; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidine-2,4-dione; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione; RefChem:6340; DTXCID001030648; 200-407-5; Uracil, 1-beta-D-ribofuranosyl-; MFCD00006526; 1-.beta.-D-Ribofuranosyluracil; beta-Uridine; NSC 20256; AI3-52690; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; Urd; C9H12N2O6; MLS000069625; SMR000058222; 92487-68-8; 69-75-0; b-Uridine; Uridine-15N2; 1-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-dihydropyrimi dine-2,4-dione; EINECS 200-407-5; UNII-WHI7HQ7H85; 1-beta-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione (Uridine); araU; Uridine-t; d-Ribosyl uracil; .beta.-Uridine; Uridine (Standard); 1af2; 4jx9; 4pd6; Opera_ID_118; Uridine, >=99%; URIDINE [MI]; URIDINE [MART.]; 1-b-D-Ribofuranosyluracil; URIDINE [USP-RS]; URIDINE [WHO-DD]; 1-A-D-Ribofuranosyluracil; bmse000158; bmse000816; bmse000864; Epitope ID:149164; 1-.beta.-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione; beta-D-ribofuranosyl-uridine; SCHEMBL20667; Uracil-1-A-D-ribofuranoside; rg2417; Uridine, BioUltra, >=99%; Uracil-1-beta-d-ribofuranoside; URIDINE [USP IMPURITY]; CHEMBL100259; GTPL4566; orb1224558; orb1306071; SCHEMBL3370976; SCHEMBL8600376; SCHEMBL9177985; SCHEMBL9179675; 1-beta-delta-Ribofuranosyluracil; HY-B1449R; MSK6806; Uracil-1-.beta.-d-ribofuranoside; HMS2230P13; HMS3884M20; HY-B1449; BDBM50088517; EBC-08618; SBB000838; AKOS015896922; CCG-214447; CS-5153; DB02745; NU06309; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; SMP1_000029; NCGC00017312-02; NCGC00017312-04; NCGC00017312-05; NCGC00142368-01; BP-58653; DS-14345; SRI-10895_12; ST023512; SY005419; Uridine, Vetec(TM) reagent grade, 99%; ADENOSINE IMPURITY F [EP IMPURITY]; DB-030519; NS00014580; T2221; U0020; C00299; EN300-221746; 1-b-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione; b-D-Ribofuranoside 2,4(1H,3H)-pyrimidinedione-1; F078878; Q422573; BRD-K13050303-001-17-3; BRD-K13050303-001-18-1; Uridine, powder, BioReagent, suitable for cell culture; .beta.-D-Ribofuranoside, 2,4(1H,3H)-pyrimidinedione-1; 1-beta-delta-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione; 6B6FA3F8-70A2-44EA-B99C-D35D0A9237AA; beta-delta-Ribofuranoside 2,4(1H,3H)-pyrimidinedione-1; Z1741976658; Uridine; Adenosine EP Impurity F; Cytarabine EP Impurity B; 1-.BETA.-D-RIBOFURANOSYLPYRIMIDINE-2,4(1H,3H)-DIONE; Uridine, United States Pharmacopeia (USP) Reference Standard; Uridine (dưới các dạng muối sodium phosphat)동의어